Heinen, E. (2002). Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration. Journal of Veterinary Pharmacology and Therapeutics, 25(1), 1–5. https://doi.org/10.1046/j.1365-2885.2002.00381.x
Küng, K., Riond, J. L., & Wanner, M. (1993). Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 16(4), 462–468. https://doi.org/10.1111/j.1365-2885.1993.tb00212.x
Cester, C. C., & Toutain, P. L. (1997). A comprehensive model for enrofloxacin to ciprofloxacin transformation and disposition in dog. Journal of Pharmaceutical Sciences, 86(10), 1148–1155. https://doi.org/10.1021/js9603461
Boothe, D. M., Boeckh, A., Boothe, H. W., Wilkie, S., & Jones, S. (2002). Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg. Veterinary Therapeutics: Research in Applied Veterinary Medicine, 3(4), 409–419.
Bidgood, T. L., & Papich, M. G. (2005). Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs. Journal of Veterinary Pharmacology and Therapeutics, 28(4), 329–341. https://doi.org/10.1111/j.1365-2885.2005.00664.x
